California’s Bureau of Cannabis Control suspended hundreds of business licenses this month, citing missed deadlines in the state’s mandate to get everyone onboard with track-and-trace training. The plan was to have the BCC’s 2,630 licensed businesses credentialed in the state system by the end of October. The suspensions are in place for those businesses still lagging in compliance.
All told, the BCC froze the licensed status of 407 cannabis business. The BCC oversees businesses licensed for cannabis retail, delivery, distribution and manufacturing.
California’s Cannabis Track-and-Trace system (CCTT) is powered by Metrc. The roll-out of this system began in January.
Josh Drayton of the California Cannabis Industry Association told the Associated Press that this sort of bottleneck in the supply chain ends up counterproductive for the legal industry’s goals in California. “We’re kind of incentivizing the illicit market, which is a much more affordable option right now for consumers,” he said. “What we really need to be focused on is access and affordability.”
PRESS RELEASE - HUB International (HUB) recently named Jay Virdi Chief Sales Officer for its cannabis insurance and risk services in the U.S. and Canada. Virdi most recently developed and managed the cannabis practice group for a North American specialty risks MGA. He has become a reputable leader in the advocacy for risk management and innovative insurance solutions in cannabis for clients, brokers and insurance providers.
As Chief Sales Officer, Virdi will focus on further developing and perpetuating deep expertise and resources across the U.S. and Canada, to provide medical and recreational cannabis producers, distributors and retailers proper protection and specialized solutions to reduce risks in all aspects of their operations.
Virdi has more than 15 years of experience in the insurance industry providing support for sales activities and operations, including the execution of strategic initiatives. He has experience advising on commercial lines insurance solutions and underwriting complex risks and commercial programs. Additionally, Virdi was a global sales consultant where he advised insurance carriers using big data analytics. His insightful recommendations resulted in the creation of innovative new products, identifying areas of opportunity for revenue generation and establishing meaningful key stakeholder engagement.
Virdi is a Chartered Insurance Professional (CIP) from the Insurance Institute of Canada. He holds an Honors Bachelors of Arts (Hon. BA) degree in Economics and Business Management from the University of Toronto and a Digital Certification in Communications, Culture and Information Technology (CCIT) from Sheridan College.
ATLANTA, Nov. 12, 2019 /PRNewswire/ -- PRESS RELEASE -- Parallel, formerly Surterra Wellness, a company that is pioneering human well-being through its proprietary cannabinoid brands, science and technology-led innovation, has announced that Kevin Fisher has been named Chief Operating Officer (COO), effective immediately. As COO, Fisher will have responsibility for Parallel's core day-to-day business operations and will lead the commercial and operational implementation of corporate strategy across Parallel's four current operating markets of Florida, Massachusetts, Texas and Nevada. Fisher reports directly to Parallel's Chairman and Chief Executive Officer, William "Beau" Wrigley, Jr.
"Kevin is an accomplished leader with deep cannabis industry experience and a proven track record of delivering operational excellence across all areas of the business," said Wrigley. "As a critical driver of Parallel's continued growth, he will lead day-to-day execution of corporate strategy, ensuring organic growth in our operating markets by quickly and effectively meeting consumer demand for consistent, safe, quality products. Kevin's appointment is emblematic of our continued evolution over the past year and of our focus on establishing a best-in-class company led by the industry's most dynamic and experienced executive team."
Fisher is an industry pioneer in the regulated medical and adult-use cannabis industry, and co-founder and former CEO of New England Treatment Access (NETA) and Molecular Infusions (Mi). Prior to his transition to COO, he has served as Executive Director of Operations at Parallel and was responsible for instilling operational excellence and best practices in the company's customer care, research and development, product production, compliance, and year-round indoor cultivation capabilities. Kevin is also a member of Parallel's Board of Directors. Prior to joining Parallel, Fisher founded and operated three cannabis-focused companies: Rocky Mountain Remedies (2009), one of the first licensees in Colorado, NETA (2013), the leading cannabis company in Massachusetts, and Molecular Infusions (Mi), a world-class, cannabinoid-focused, biopharmaceutical company based in Boston. Fisher served as CEO of both NETA and Mi prior to Parallel, then Surterra Wellness, which acquired the companies in 2019.
"I am energized to take on this new role as COO and look forward to continuing my partnership with Beau and our entire executive leadership team to deliver on our 2020 corporate strategy and priorities," said Fisher. "I have spent the majority of my career establishing, growing and leading companies by operating with speed, efficiency and scalability while placing a particular focus on compliance with federal and state regulations. I look forward to applying my experience to bringing well-being through cannabinoids to customers in the U.S. and across the globe."
VANCOUVER, British Columbia, Nov. 12, 2019 (GLOBE NEWSWIRE) -- PRESS RELEASE -- Rubicon Organics Inc. has successfully completed its first commercial-scale harvest of certified organic, super-premium cannabis at the company’s flagship 125,000-square-foot hybrid greenhouse facility in Delta, B.C. The harvest passed all microbiology and contaminant testing to be fully compliant with Health Canada standards and has enabled the company to submit its sales license amendment with Health Canada--marking a significant milestone in the company’s execution strategy as it moves towards brand launch in Canada.
“The success of our first commercial-scale harvest is proof that Rubicon Organics’ proprietary cultivation methods--developed over years of research and development--can grow fully compliant, exceptional quality, certified organic cannabis at scale in Canada,” stated Jesse McConnell, CEO of Rubicon Organics. “We are very proud of our dedicated cultivation team which has fully delivered against the design expectations and target yields of our hybrid facility in Delta. We are now moving down the path towards securing our sales license to bring high-quality, certified organic products directly to the market in the coming months.”
Rubicon Organics’ initial commercial-scale crop was planted in mid-June and harvested from the end of September to mid-October. The crop has passed analytical testing to ensure safety and compliance with Health Canada standards, which places stringent limits on the presence of heavy metals, pesticides, microorganisms, mold and other contaminants. The crop has now been dried, bulk packaged and will be entering the final packaging stage in preparation for brand launch.
Rubicon Organics’ fully licensed 125,000-square-foot facility in Delta has approximately 80,000 square feet of flowering canopy space divided into five climate-controlled compartments with LED lighting. The company’s first commercial-scale crop was planted in and harvested from the first of these compartments. Construction and planting of the four remaining cultivation compartments are expected to be complete prior to the end of 2019.
As new compartments are completed, additional crops are planted in stages in order to achieve full production capacity which is estimated to be 11,000 kg per year. Once the facility is fully planted, the company intends to maximize efficiencies and ensure a consistent supply of fresh flower through a perpetual harvest strategy that targets a harvest every 2.5 weeks.
Sales Amendment Update
Having now arrived at a saleable product, Rubicon Organics has initiated the application process for a sales license amendment with Health Canada in order to sell directly to provincial distributors. Dependent on Health Canada approval timelines, the company expects to receive its sales license amendment in the first half of 2020.
Cannabis Business Times’ interactive legislative map is another tool to help cultivators quickly navigate state cannabis laws and find news relevant to their markets. View More